0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Elastosis Perforans Serpiginosa A Case of a Penicillamine-Induced Degenerative Dermatosis FREE

Simin Hellriegel, MD1; Hans P. Bertsch, MD1; Steffen Emmert, MD1; Michael P. Schön, MD1; Holger A. Haenssle, MD1
[+] Author Affiliations
1Clinic of Dermatology, Venereology and Allergology, University Medical Center, Georg-August-University, Göttingen, Germany
JAMA Dermatol. 2014;150(7):785-787. doi:10.1001/jamadermatol.2013.8635.
Text Size: A A A
Published online

REPORT OF A CASE

A man in his 60s presented in reduced general condition and with asymptomatic brownish-red papules organized in multiple arcuate to annular formations on his upper trunk and arms (Figure 1). A prominent cutis laxa and cutis rhomboidalis nuchae were noted. At the time of presentation, he had been treated for Wilson disease with daily doses of D-penicillamine (1.0-1.5 g/d) for more than 40 years.

Place holder to copy figure label and caption
Figure 1.
Clinical Images of D-Penicillamine–Induced Elastosis Perforans Serpiginosa

A, Overview, with black frame enclosing the affected area shown in panel B; the abnormal posture of the patient is a symptom of rigid dystonia. B, Close-up image of the framed area from panel A showing prominent cutis laxa and annular confluent patches with a central skin atrophy and a peripheral rim of red papules covered by white-yellow scales (scale bars indicate centimeters). Sun-exposed nuchal skin showed increased elastosis with severe cutis laxa and cutis rhomboidalis nuchae.

Graphic Jump Location

Histopathologic analysis revealed channels through the epidermis formed by follicular epithelium (Figure 2A). The infundibula were filled with granular cellular debris, neutrophils, and corneocytes (Figure 2A and C). The interfollicular tissue showed a mixed inflammatory infiltrate. Elastica van Gieson staining demonstrated an accumulation of altered elastic fibers (Figure 2B) within the upper part of the dermis.

Place holder to copy figure label and caption
Figure 2.
Histopathologic Images of D-Penicillamine–Induced Elastosis Perforans Serpiginosa

A, Transepidermal/follicular channels through the surface epithelium that contain basophilic necrotic material (hematoxylin-eosin, original magnification ×40). B, Elastica van Gieson–stained sections showing accumulation of abnormal elastic fibers in the upper part of the dermis; inset shows “lumpy-bumpy” fibers indicating induction by penicillamine (original magnifications ×40 for main panel, ×400 for inset). C, Suppurative folliculitis with transinfundibular elimination of altered elastic fibers (hematoxylin-eosin, original magnification ×100).

Graphic Jump Location

From the clinical and histopathologic findings, the diagnosis of elastosis perforans serpiginosa (EPS), caused by long-term ingestion of D-penicillamine, was made.

DISCUSSION

Wilson disease is a rare autosomal recessive condition caused by a genetic defect in the copper-transporting ATPase ATP7B.1,2 Copper accumulation in the liver and the basal ganglia of the brain may lead to hepatocerebral degeneration. In our patient, liver transaminase levels were slightly elevated, and neurologic symptoms included ataxia and rigid dystonia.

An effective treatment for Wilson disease is D-penicillamine, a chelating agent that depletes copper. In addition, successful treatment has also been reported with trientine dihydrochloride, zinc, tetrathiomolybdate, and liver transplantation.2 Long-term D-penicillamine therapy can induce EPS by reducing the activity of lysyl-oxidase, a copper-dependent enzyme that cross-links dermal elastic fibers, and by formation of complexes with precursors of elastic fibers, thus impairing their maturation.3 As a result, abnormal elastin aggregates promote a foreign body reaction with subsequent transepidermal elimination.

Clinically, EPS lesions present with multiple keratotic papules arranged in arcuate or circinate patterns. Lesions are typically found on the neck and upper extremities. Much less frequently cutis laxa has been described as an adverse effect of D-penicillamine.4 Morphologic changes of the elastic fibers of arteries and pulmonary tissue are a matter of concern. In our patient, the findings of chest and cardiovascular examinations were unremarkable.

Histopathologically, an acanthotic, hyperkeratotic epidermis with a mixed dermal inflammatory infiltrate with few giant cells is present in EPS. Epidermal invaginations with keratotic plugs at the surface form perforating channels filled with basophilic material. Atrophy of the skin may be found at the center of lesions. Elastic fiber stain shows a thickened and coarse morphology giving rise to the typical “lumpy-bumpy” picture.5

Our patient had been taking D-penicillamine for more than 40 years, well above the average 10-year interval after which EPS may be acquired. For patients with cutaneous or systemic D-penicillamine adverse effects, an alternative copper-chelating agent like trientine dihydrochloride may be used.2 To our knowledge, no elastolytic dermatoses have been associated with trientine dihydrochloride therapy. Therefore, we recommended that the patient shift oral treatment from D-penicillamine to trientine dihydrochloride in this interdisciplinary case. For the remaining lesions, we offered liquid nitrogen cryotherapy or ablative laser resurfacing to the patient. Unfortunately, the patient was subsequently lost to follow-up.

ARTICLE INFORMATION

Corresponding Author: Holger A. Haenssle, MD, Clinic of Dermatology, Venereology and Allergology, University Medical Center, Georg-August-University, Göttingen, Robert-Koch Strasse 40, 37075 Göttingen, Germany (h.haenssle@med.uni-goettingen.de).

Published Online: April 16, 2014. doi:10.1001/jamadermatol.2013.8635.

Conflict of Interest Disclosures: None reported.

REFERENCES

Bull  PC, Thomas  GR, Rommens  JM, Forbes  JR, Cox  DW.  The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5(4):327-337.
PubMed   |  Link to Article
Roberts  EA, Schilsky  ML; American Association for Study of Liver Diseases (AASLD).  Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089-2111.
PubMed   |  Link to Article
Iozumi  K, Nakagawa  H, Tamaki  K.  Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses. J Dermatol. 1997;24(7):458-465.
PubMed
Rosen  LB, Muellenhoff  M, Tran  TT, Muhart  M.  Elastosis perforans serpiginosa secondary to D-penicillamine therapy with coexisting cutis laxa. Cutis. 2005;76(1):49-53.
PubMed
Bardach  H, Gebhart  W, Niebauer  G.  “Lumpy-bumpy” elastic fibers in the skin and lungs of a patient with a penicillamine-induced elastosis perforans serpiginosa. J Cutan Pathol. 1979;6(4):243-252.
PubMed   |  Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.
Clinical Images of D-Penicillamine–Induced Elastosis Perforans Serpiginosa

A, Overview, with black frame enclosing the affected area shown in panel B; the abnormal posture of the patient is a symptom of rigid dystonia. B, Close-up image of the framed area from panel A showing prominent cutis laxa and annular confluent patches with a central skin atrophy and a peripheral rim of red papules covered by white-yellow scales (scale bars indicate centimeters). Sun-exposed nuchal skin showed increased elastosis with severe cutis laxa and cutis rhomboidalis nuchae.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Histopathologic Images of D-Penicillamine–Induced Elastosis Perforans Serpiginosa

A, Transepidermal/follicular channels through the surface epithelium that contain basophilic necrotic material (hematoxylin-eosin, original magnification ×40). B, Elastica van Gieson–stained sections showing accumulation of abnormal elastic fibers in the upper part of the dermis; inset shows “lumpy-bumpy” fibers indicating induction by penicillamine (original magnifications ×40 for main panel, ×400 for inset). C, Suppurative folliculitis with transinfundibular elimination of altered elastic fibers (hematoxylin-eosin, original magnification ×100).

Graphic Jump Location

Tables

References

Bull  PC, Thomas  GR, Rommens  JM, Forbes  JR, Cox  DW.  The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5(4):327-337.
PubMed   |  Link to Article
Roberts  EA, Schilsky  ML; American Association for Study of Liver Diseases (AASLD).  Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089-2111.
PubMed   |  Link to Article
Iozumi  K, Nakagawa  H, Tamaki  K.  Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses. J Dermatol. 1997;24(7):458-465.
PubMed
Rosen  LB, Muellenhoff  M, Tran  TT, Muhart  M.  Elastosis perforans serpiginosa secondary to D-penicillamine therapy with coexisting cutis laxa. Cutis. 2005;76(1):49-53.
PubMed
Bardach  H, Gebhart  W, Niebauer  G.  “Lumpy-bumpy” elastic fibers in the skin and lungs of a patient with a penicillamine-induced elastosis perforans serpiginosa. J Cutan Pathol. 1979;6(4):243-252.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

981 Views
3 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs